Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 02, 2008

Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity

Dec 01, 2008

Mylan Confirms First-to-File Patent Challenge Relating to AMRIX(R)

Nov 18, 2008

Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem ( R) Pulvules( R) Capsules

Nov 17, 2008

Mylan Receives Tentative FDA Approval for the Generic Version of the Antidepressant Effexor XR(R)

Nov 06, 2008

Mylan's Dey L.P. Announces Establishment of 'J-Code' for Perforomist(TM) Inhalation Solution

Nov 04, 2008

Mylan Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately

Oct 30, 2008

Mylan Declares Quarterly Preferred Stock Dividend

Oct 30, 2008

Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008

Oct 29, 2008

Mylan's Matrix First-to-File on Generic Version of Vfend(R) Antifungal

Oct 22, 2008

Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)

Pagination

First page
Previous page
…
Page 88
Page 89
Page 90
Page 91
Current page 92
Page 93
Page 94
Page 95
Page 96
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.